UBS Group
AKAO

UBS Group’s Achaogen Inc AKAO Stock Holding History

UBS Group’s Portfolio AKAO Stock Details AKAO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-31,039
Closed -$14K – 8474
2019
Q1 		$14K Buy
31,039
+30,039
+3,004% +$31.5K ﹤0.01% 6622
2018
Q4 		$1K Hold
1,000
– – ﹤0.01% 7969
2018
Q3 		$4K Sell
1,000
-1,500
-60% -$9.07K ﹤0.01% 7619
2018
Q2 		$22K Sell
2,500
-295,132
-99% -$3.6M ﹤0.01% 6647
2018
Q1 		$3.85M Buy
297,632
+259,546
+681% +$2.94M ﹤0.01% 2550
2017
Q4 		$409K Sell
38,086
-18,868
-33% -$237K ﹤0.01% 4438
2017
Q3 		$908K Sell
56,954
-18,526
-25% -$353K ﹤0.01% 3788
2017
Q2 		$1.64M Buy
75,480
+29,992
+66% +$685K ﹤0.01% 3184
2017
Q1 		$1.15M Buy
45,488
+41,943
+1,183% +$862K ﹤0.01% 3419
2016
Q4 		$47K Buy
3,545
+2,045
+136% +$14K ﹤0.01% 5878
2016
Q3 		$7K Hold
1,500
– – ﹤0.01% 7014
2016
Q2 		$6K Hold
1,500
– – ﹤0.01% 7074
2016
Q1 		$4K Sell
1,500
-1,885
-56% -$7.33K ﹤0.01% 7132
2015
Q4 		$20K Buy
3,385
+1,885
+126% +$10.8K ﹤0.01% 6777
2015
Q3 		$9K Hold
1,500
– – ﹤0.01% 7366
2015
Q2 		$9K Hold
1,500
– – ﹤0.01% 7569
2015
Q1 		$15K Sell
1,500
-57
-4% -$643 ﹤0.01% 7307
2014
Q4 		$21K Buy
+1,557
New +$15.8K ﹤0.01% 7628

Other funds holding AKAO

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
GI
GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

UBS Group's AKAO Position: Q2 2019 in Review

UBS Group sold out of Achaogen Inc (AKAO) in Q2 2019, closing a stake of 31,039 shares — an estimated $14K sold.

UBS Group first reported a position in AKAO in Q4 2014 and held it in 18 quarters. The position peaked at $3.85M in Q1 2018. 8 funds tracked by Wall St. Rank hold AKAO as of Q2 2019.

  • UBS Group reported no remaining Achaogen Inc position as of Q2 2019 after selling out during the quarter.
  • UBS Group sold 31,039 Achaogen Inc shares in Q2 2019, an estimated $14K.
  • UBS Group first reported a position in Achaogen Inc in Q4 2014 and held it in 18 quarters.
  • UBS Group's Achaogen Inc position peaked at $3.85M in Q1 2018.
  • 8 funds tracked by Wall St. Rank held Achaogen Inc as of Q2 2019.

Based on UBS Group's 13F filing for Q2 2019, filed 14 Aug 2019.